Daniel Schneeberger, 10% Owner at Keros Therapeutics, Inc. (KROS), sold 10,778,528 shares at $17.75 ($191.3M) on 2025-10-15, disclosed to the SEC on 2025-10-15.
Open-market sale of $191.3M KROS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.75 | 254,669 | $4.5M | 2.4% |
| 2 | $17.75 | 254,669 | $4.5M | 2.4% |
| 3 | $17.75 | 743,358 | $13.2M | 6.9% |
| 4 | $17.75 | 743,358 | $13.2M | 6.9% |
| 5 | $17.75 | 4,391,237 | $77.9M | 40.7% |
| 6 | $17.75 | 4,391,237 |
| $77.9M |
| 40.7% |
| Total | $17.75 avg | 10,778,528 | $191.3M | 100% |